Definitive Contract HHS261025139
Award Date
9/30/05
Potential Completion Date
9/29/06
Potential Value
$4.4M
Funding Federal Agency
Not listed
Contracting Federal Agency
National Cancer Institute
Awardee
University Of California Irvine
Ultimate Awardee
Not listed
NAICS Category
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Irvine, CA 92697, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a definitive federal contract awarded by the National Institutes of Health (NIH) to the University of California, Irvine (UC Irvine) for a clinical trial. The contract was awarded on June 30, 2004 with a potential value of $33,037,337.00. The contract does not have a set-aside designation and is scheduled for completion on September 30, 2010. UC Irvine, a major public research university, has extensive experience delivering research and development (R&D) services to various federal...
This is a prime contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to the University of California Irvine (UC Irvine) for Phase I and II clinical trials of cancer chemopreventive agents. The $13,886,589.26 definitive contract does not have a set-aside designation, as UC Irvine was selected based on its extensive research capabilities and expertise in biomedical sciences. The contract supports the development of novel cancer prevention...
This federal contract award, valued at $8,762,844.00, was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (DHHS). The contract was awarded to the University of California, Irvine (UC Irvine) to conduct a research program comparing multiple vaccine adjuvants across various platforms. The goal is to establish immunological profiles of the adjuvants' strength,...
The U.S. Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) awarded a $473,538 firm-fixed-price definitive contract to the University of California Irvine (UC Irvine) to support COVID-19 research under Broad Agency Announcement (BAA) Topic 1.3. The contract has a completion date of September 30, 2022. UC Irvine, a major public research university, has a history of federal R&D awards from agencies such as the Department of Defense, NASA, NSF, and...
This is a $5,032,836.19 Definitive Contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the Department of Health and Human Services, to the University of California, Irvine (UC Irvine). The contract is for biomedical research and exploration, and does not have a set-aside designation. UC Irvine, a non-profit research university, has extensive expertise in biomedicine, engineering, and other disciplines. The university frequently...
The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a $3,116 firm-fixed-price purchase order to the University of California, Irvine (UC Irvine) for a quantitative 3-way analysis of vaccinia virus via mass spectrometry. This award does not have a set-aside designation. UC Irvine is a public research university that frequently supports government agencies through contract and grant awards, leveraging its specialized facilities, faculty expertise, and research...
This is a $113,615 federal contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to the University of California Irvine for "POST-DISCHARGE S.AUREUS INFECTION" services. The contract is a definitive, firm fixed price contract with a completion date of September 29, 2019. UC Irvine is a major public research university that has previously provided research and development services to various federal agencies including the Department...
This is a definitive federal contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases, a civilian agency, to the University of California Irvine (UC Irvine) for a TAS HALT C STUDY with a ceiling value of $178,646.17. The contract does not have a set-aside designation, as UC Irvine competes for awards based on its research capabilities rather than small business status. UC Irvine is a public research university with extensive expertise across various disciplines,...
This is a firm-fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA), Veterans Integrated Service Network 22 to the University of California, Irvine (UC Irvine) for $16,416.72 in research and development services. The contract has a period of performance ending on February 21, 2025 and does not have a set-aside designation. UC Irvine is a public research university known for its expertise across disciplines including biomedicine, engineering, and physical...
This federal contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to the University of California Irvine (UC Irvine), a major public research university. The $412,739.00 definitive, firm-fixed-price contract is for evaluating changes in skin cultures and skin microbiome due to chlorhexidine vs. soap bathing. The contract has no set-aside designation and was originally solicited through the CDC's Fiscal Year 2019 Broad Agency...